Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT)

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
28,406,191
Total 13F shares
22,638,074
Share change
+622,215
Total reported value
$383,920,663
Put/Call ratio
45%
Price per share
$16.96
Number of holders
111
Value change
+$11,521,684
Number of buys
55
Number of sells
50

Institutional Holders of Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) as of Q4 2022

As of 31 Dec 2022, Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,638,074 shares. The largest 10 holders included FEDERATED HERMES, INC., STATE STREET CORP, ARK Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Balyasny Asset Management LLC, FMR LLC, and Woodline Partners LP. This page lists 111 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.